Global Peptide Therapeutics Competitive Landscape Professional Research Report 2024

Research Summary

Peptide therapeutics are a class of pharmaceutical drugs composed of short chains of amino acids, known as peptides, that are designed to target specific biological molecules or pathways to treat various medical conditions and diseases. These therapeutic peptides can mimic the activity of natural peptides or proteins in the body, regulate or inhibit certain biochemical processes, and interact with specific receptors or enzymes. They are highly precise and often have fewer side effects compared to traditional small-molecule drugs. Peptide therapeutics have been developed for a wide range of medical applications, including treating cancer, diabetes, autoimmune disorders, infectious diseases, and more. Due to their specificity and effectiveness, peptide-based drugs have gained significant attention in the pharmaceutical industry, and ongoing research and development continue to expand the use of peptide therapeutics for various healthcare needs.

According to DIResearch's in-depth investigation and research, the global Peptide Therapeutics market size will reach US$ XX Million in 2024, and is expected to reach US$ XX Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be US$ XX Million, accounting for approximately XX% of the world. It is expected to reach US$ XX Million in 2030, and the global share will reach XX%.

The major global manufacturers of Peptide Therapeutics include Sanofi, Teva, Novo Nordisk, Takeda, Eli Lilly, AstraZeneca, Novartis, AbbVie, Ipsen, Ferring, Merck, The Medicines, Johnson & Johnson etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.

This report studies the market size, price trends and future development prospects of Peptide Therapeutics. Focus on analysing the market share, product portfolio, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Peptide Therapeutics market. The report data covers historical data from 2019 to 2023, base year in 2024 and forecast data from 2025 to 2030.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Peptide Therapeutics market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Peptide Therapeutics industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Peptide Therapeutics Include:

Sanofi

Teva

Novo Nordisk

Takeda

Eli Lilly

AstraZeneca

Novartis

AbbVie

Ipsen

Ferring

Merck

The Medicines

Johnson & Johnson

Peptide Therapeutics Product Segment Include:

Injection

Oral

Others

Peptide Therapeutics Product Application Include:

Cancer

Metabolic Disorders

Central Nervous System

Others

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global Peptide Therapeutics Industry PESTEL Analysis

Chapter 3: Global Peptide Therapeutics Industry Porter's Five Forces Analysis

Chapter 4: Global Peptide Therapeutics Major Regional Market Size and Forecast Analysis

Chapter 5: Global Peptide Therapeutics Market Size and Forecast by Type and Application Analysis

Chapter 6: North America Peptide Therapeutics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe Peptide Therapeutics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China Peptide Therapeutics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) Peptide Therapeutics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America Peptide Therapeutics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa Peptide Therapeutics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global Peptide Therapeutics Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources

Table of Contents

1 Peptide Therapeutics Market Overview

1.1 Product Definition and Statistical Scope

1.2 Peptide Therapeutics Product by Type

1.2.1 Global Peptide Therapeutics Market Size by Type, 2023 VS 2024 VS 2030

1.2.2 Injection

1.2.3 Oral

1.2.4 Others

1.3 Peptide Therapeutics Product by Application

1.3.1 Global Peptide Therapeutics Market Size by Application, 2023 VS 2024 VS 2030

1.3.2 Cancer

1.3.3 Metabolic Disorders

1.3.4 Central Nervous System

1.3.5 Others

1.4 Global Peptide Therapeutics Market Revenue Analysis (2019-2030)

1.5 Peptide Therapeutics Market Development Status and Trends

1.5.1 Peptide Therapeutics Industry Development Status Analysis

1.5.2 Peptide Therapeutics Industry Development Trends Analysis

2 Peptide Therapeutics Market PESTEL Analysis

2.1 Political Factors Analysis

2.2 Economic Factors Analysis

2.3 Social Factors Analysis

2.4 Technological Factors Analysis

2.5 Environmental Factors Analysis

2.6 Legal Factors Analysis

3 Peptide Therapeutics Market Porter's Five Forces Analysis

3.1 Competitive Rivalry

3.2 Threat of New Entrants

3.3 Bargaining Power of Suppliers

3.4 Bargaining Power of Buyers

3.5 Threat of Substitutes

4 Global Peptide Therapeutics Market Analysis by Regions

4.1 Peptide Therapeutics Overall Market: 2023 VS 2024 VS 2030

4.2 Global Peptide Therapeutics Revenue and Forecast Analysis (2019-2030)

4.2.1 Global Peptide Therapeutics Revenue and Market Share by Region (2019-2024)

4.2.2 Global Peptide Therapeutics Revenue Forecast by Region (2025-2030)

5 Global Peptide Therapeutics Market Size by Type and Application

5.1 Global Peptide Therapeutics Market Size by Type

5.2 Global Peptide Therapeutics Market Size by Application

6 North America

6.1 North America Peptide Therapeutics Market Size and Growth Rate Analysis (2019-2030)

6.2 North America Key Manufacturers Analysis

6.3 North America Peptide Therapeutics Market Size by Type

6.4 North America Peptide Therapeutics Market Size by Application

6.5 North America Peptide Therapeutics Market Size by Country

6.5.1 US

6.5.2 Canada

7 Europe

7.1 Europe Peptide Therapeutics Market Size and Growth Rate Analysis (2019-2030)

7.2 Europe Key Manufacturers Analysis

7.3 Europe Peptide Therapeutics Market Size by Type

7.4 Europe Peptide Therapeutics Market Size by Application

7.5 Europe Peptide Therapeutics Market Size by Country

7.5.1 Germany

7.5.2 France

7.5.3 United Kingdom

7.5.4 Italy

7.5.5 Spain

7.5.6 Benelux

8 China

8.1 China Peptide Therapeutics Market Size and Growth Rate Analysis (2019-2030)

8.2 China Key Manufacturers Analysis

8.3 China Peptide Therapeutics Market Size by Type

8.4 China Peptide Therapeutics Market Size by Application

9 APAC (excl. China)

9.1 APAC (excl. China) Peptide Therapeutics Market Size and Growth Rate Analysis (2019-2030)

9.2 APAC (excl. China) Key Manufacturers Analysis

9.3 APAC (excl. China) Peptide Therapeutics Market Size by Type

9.4 APAC (excl. China) Peptide Therapeutics Market Size by Application

9.5 APAC (excl. China) Peptide Therapeutics Market Size by Country

9.5.1 Japan

9.5.2 South Korea

9.5.3 India

9.5.4 Australia

9.5.5 Indonesia

9.5.6 Vietnam

9.5.7 Malaysia

9.5.8 Thailand

10 Latin America

10.1 Latin America Peptide Therapeutics Market Size and Growth Rate Analysis (2019-2030)

10.2 Latin America Key Manufacturers Analysis

10.3 Latin America Peptide Therapeutics Market Size by Type

10.4 Latin America Peptide Therapeutics Market Size by Application

10.5 Latin America Peptide Therapeutics Market Size by Country

10.5.1 Mecixo

10.5.2 Brazil

11 Middle East & Africa

11.1 Middle East & Africa Peptide Therapeutics Market Size and Growth Rate Analysis (2019-2030)

11.2 Middle East & Africa Key Manufacturers Analysis

11.3 Middle East & Africa Peptide Therapeutics Market Size by Type

11.4 Middle East & Africa Peptide Therapeutics Market Size by Application

11.5 Middle East & Africa Peptide Therapeutics Market Size by Country

11.5.1 Saudi Arabia

11.5.2 South Africa

12 Market Competition by Manufacturers

12.1 Global Peptide Therapeutics Market Revenue by Key Manufacturers (2020-2024)

12.2 Peptide Therapeutics Competitive Landscape Analysis and Market Dynamic

12.2.1 Peptide Therapeutics Competitive Landscape Analysis

12.2.2 Global Key Manufacturers Headquarter and Key Area Sales

12.2.3 Market Dynamic

13 Key Companies Analysis

13.1 Sanofi

13.1.1 Sanofi Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.1.2 Sanofi Peptide Therapeutics Product Portfolio

13.1.3 Sanofi Peptide Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.2 Teva

13.2.1 Teva Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.2.2 Teva Peptide Therapeutics Product Portfolio

13.2.3 Teva Peptide Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.3 Novo Nordisk

13.3.1 Novo Nordisk Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.3.2 Novo Nordisk Peptide Therapeutics Product Portfolio

13.3.3 Novo Nordisk Peptide Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.4 Takeda

13.4.1 Takeda Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.4.2 Takeda Peptide Therapeutics Product Portfolio

13.4.3 Takeda Peptide Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.5 Eli Lilly

13.5.1 Eli Lilly Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.5.2 Eli Lilly Peptide Therapeutics Product Portfolio

13.5.3 Eli Lilly Peptide Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.6 AstraZeneca

13.6.1 AstraZeneca Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.6.2 AstraZeneca Peptide Therapeutics Product Portfolio

13.6.3 AstraZeneca Peptide Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.7 Novartis

13.7.1 Novartis Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.7.2 Novartis Peptide Therapeutics Product Portfolio

13.7.3 Novartis Peptide Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.8 AbbVie

13.8.1 AbbVie Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.8.2 AbbVie Peptide Therapeutics Product Portfolio

13.8.3 AbbVie Peptide Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.9 Ipsen

13.9.1 Ipsen Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.9.2 Ipsen Peptide Therapeutics Product Portfolio

13.9.3 Ipsen Peptide Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.10 Ferring

13.10.1 Ferring Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.10.2 Ferring Peptide Therapeutics Product Portfolio

13.10.3 Ferring Peptide Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.11 Merck

13.11.1 Merck Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.11.2 Merck Peptide Therapeutics Product Portfolio

13.11.3 Merck Peptide Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.12 The Medicines

13.12.1 The Medicines Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.12.2 The Medicines Peptide Therapeutics Product Portfolio

13.12.3 The Medicines Peptide Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.13 Johnson & Johnson

13.13.1 Johnson & Johnson Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.13.2 Johnson & Johnson Peptide Therapeutics Product Portfolio

13.13.3 Johnson & Johnson Peptide Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

14 Industry Chain Analysis

14.1 Peptide Therapeutics Industry Chain Analysis

14.2 Peptide Therapeutics Industry Raw Material and Suppliers Analysis

14.2.1 Upstream Key Raw Material Supply Analysis

14.2.2 Raw Material Suppliers and Contact Information

14.3 Peptide Therapeutics Typical Downstream Customers

14.4 Peptide Therapeutics Sales Channel Analysis

15 Research Findings and Conclusion

16 Methodology and Data Source

16.1 Methodology/Research Approach

16.2 Research Scope

16.3 Benchmarks and Assumptions

16.4 Date Source

16.4.1 Primary Sources

16.4.2 Secondary Sources

16.5 Data Cross Validation

16.6 Disclaimer

Name*

Email ID*

Company*

Phone (With Country Code)*

What is/are your question(s)?:

Publisher: DIResearch

Related Reports

Global Epilepsy Therapeutics Market (2024 Edition): Analysis By Generation (First Generation, Second Generation, Third Generation), By Route of Administration, By Type, By Region, By Country: Market Insights and Forecast (2020-2030)

Global Online Pharmacy Market (2024 Edition): Analysis By Drug Type (Over the Counter (OTC) Drugs, Prescription Drugs, Others), By Platform, By Product Type, By Region: Market Insights and Forecast (2020-2030)

Global Diagnostic X-rays Market (2024 Edition): Analysis By Type (General Radiography, Angiography, Surgical Fluoroscopy, Mobile X ray, Other Types), By End Users, By Region, By Country: Market Insights and Forecast (2020-2030)

Global Diagnostic Labs Market (2024 Edition): Analysis By Testing Services (Physiological Function Testing, General and Clinical Testing, Esoteric Testing, Specialized Testing, and Others), By Lab Type, By Application: Market Insights and Forecast (2020-2030)

Lateral Flow Assays Market By Product Type (Lateral Flow Readers {Digital/Mobile Readers and Benchtop Readers} and Kits and Reagents), By Application (Clinical Testing {Pregnancy Testing, Influenza Testing, Tuberculosis, D-Dimer Testing, and Other Clinical Testing}, Drug Abuse Testing, Veterinary Diagnostics, Food Safety & Environmental Testing, and Other Applications), By Technique (Sandwich Assay, Competitive Assay, and Multiplex Assay), By End-User (Home Care, Hospitals and Clinics, and Other End Users), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035

Why Market Study Report?

Best Price for Reports
Large Report Database
Easily Customize Reports
24/7 Email & Phone Support